Exscientia

Exscientia is a pioneering organization based in Oxford Science Park, dedicated to revolutionizing drug discovery and design through advanced AI technologies. Their mission is to set new standards in the industry by developing patient-first AI systems that optimize targets, design, experimentation, and medicine.

Exscientia's team comprises creative, passionate, and collaborative individuals who bring ingenuity, energy, and ambition to their work. They believe in making unparalleled progress towards a world where better drugs can be discovered faster. The company's core values reflect their commitment to precision, quality, and unprecedented speed in the drug discovery process.

Their AI systems are designed to challenge traditional methods by requiring each newly designed molecule to add maximum information and shorten the path to a clinical molecule. Exscientia puts AI algorithms at the heart of design and data interpretation, optimizing molecular properties in parallel for increased likelihood of discovering candidates with exquisitely balanced pharmacology.

These innovative approaches enable Exscientia to significantly reduce the number of compounds that need to be tested, improving efficiency while maintaining quality. With a focus on higher performance and faster design, they aim to deliver a clinical molecule in less than one year – a remarkable achievement in the industry.

Exscientia's work represents a revolutionary approach to drug discovery, challenging the long-standing practice of testing thousands of molecules over years before finding a single candidate for clinical trials. By putting AI at the core of their process and relying on its ability to learn more efficiently, Exscientia is driving change in the pharmaceutical industry and paving the way for better drugs discovered faster.